Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Evaluation of the Effects of Routine Stenting Versus Conventional PTCA on Death and Reinfarction
(A) Effects on death; (B) effects on reinfarction. AS = Angioplasty or Stent; BENESTENT = Belgian Netherlands Stent Study; BESMART = Bestent in Small Arteries; BOSS = Balloon Optimization versus Stent Study; CADILLAC = Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications; DESTINI = Doppler Endpoint Stenting International Investigation; EPISTENT = Evaluation of Platelet IIb/IIIa Inhibitor for Stenting; FRESCO = Florence Randomized Elective Stenting in Acute Coronary Occlusions; FROST = French Optimal Stenting Trial; GRAMI = Gianturco-Roubin in Acute Myocardial Infarction; ISAR-SMART = Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries; MAJIC = Mayo-Japan Investigation for Chronic Total Occlusion; OCBAS = Optimal Coronary Balloon Angioplasty With Provisional Stenting Versus Primary Stent; OPUS = Optimum Percutaneous Transluminal Coronary Angioplasty Compared With Routine Stent Strategy; OR = odds ratio; PASTA= Primary Angioplasty Versus Stent Implantation in Acute Myocardial Infarction; SARECCO = Stent or Angioplasty after Recanalization of Chronic Coronary Occlusions; SISA = Stenting in Small Arteries; SPACTO = Stent versus Percutaneous Angioplasty in Chronic Total Occlusion; Stent-PAMI = Stent Primary Angioplasty in MI; STENTUIM = Immediate Coronary Angioplasty with Elective Wiktor Stent Implantation Compared with Conventional Balloon Angioplasty in Acute Myocardial Infarction; TOSCA = Total Occlusion Study of Canada; other abbreviations as in Figure 2. Reprinted from Brophy et al. (22).
|
